Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
9,26 USD | +1,20 % | -4,46 % | +19,92 % |
23/04 | ASTRIA THERAPEUTICS, INC. : HC Wainwright mantiene su recomendación de compra | ZM |
09/04 | Astria Therapeutics, Inc. nombra a Sunil Agarwal miembro de su Consejo de Administración | CI |
Resumen de negocios
Número de empleados: 59
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jill Milne
FOU | Founder | 56 | 26/06/08 |
Noah Clauser
DFI | Director of Finance/CFO | 51 | 01/04/11 |
Chief Tech/Sci/R&D Officer | - | 15/07/22 | |
John Ruesch
PRN | Corporate Officer/Principal | - | 17/07/23 |
Keri McGrail
HRO | Human Resources Officer | - | 01/03/21 |
Andrew Komjathy
PRN | Corporate Officer/Principal | 61 | 25/09/19 |
Ben Harshbarger
LAW | General Counsel | 55 | 12/06/20 |
Andrea Matthews
PRN | Corporate Officer/Principal | - | 01/07/14 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ken Bate
CHM | Chairman | 73 | 01/01/14 |
Gregg Lapointe
BRD | Director/Board Member | 65 | 04/01/19 |
Director/Board Member | 75 | 05/04/16 | |
Jonathan Violin
BRD | Director/Board Member | 49 | 28/01/21 |
Jill Milne
FOU | Founder | 56 | 26/06/08 |
Hugh Cole
BRD | Director/Board Member | 59 | 26/07/19 |
Joanne Beck
BRD | Director/Board Member | 63 | 14/02/19 |
Director/Board Member | 56 | 28/01/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 54 913 061 | 48 159 943 ( 87,70 %) | 0 | 87,70 % |
Acción B | 0 | 31 107 | 0 | 0 |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+19,92 % | 502 M | |
-3,16 % | 102 mil M | |
+1,62 % | 96,29 mil M | |
+2,13 % | 22,18 mil M | |
-15,67 % | 21,2 mil M | |
-9,21 % | 18,31 mil M | |
-39,98 % | 17,38 mil M | |
-15,70 % | 16,36 mil M | |
+4,86 % | 13,97 mil M | |
+31,92 % | 12,17 mil M |
- Bolsa de valores
- Acciones
- Acción ATXS
- Empresa Astria Therapeutics, Inc.